Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine versus duloxetine for major depressive disorder over 24 weeks
2008-004642-92Phase 3Completed
- Sponsor
- Servier
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) comparing Agomelatine with Duloxetine (2 arms). Primary endpoint: HAM-D. Started Jan 2009; status: completed.
02
Drugs
agomelatineduloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2008-004642-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004642-92.